CTIX Stock Alert 11/13/2014 15:50:23 $CTIX
No problem.
"I did not connect Operating history with Revenue."
Keep in mind that I CONCLUDED the meaning from anecdotal stuff....Every instance where I found the phrase "no operating history" the company also had no revenue. I never found a source that said "a company's operating history is measured from the time it first has revenue". If you see a reliable source that either confirms or refutes my understanding please be sure to post it.
yikes!
Look up 'Uri Geller'. Or actually track the results of 123tom's technical analysis predictions, it'll enhance your definition of informative
gosh, people that sell now...are so S !
"Most mistakes made by investors is knowing when to sell" Now is the wrong time! Wait for Leo and Menon to sell some of their shares. Familyman said it best!
That is what I have said! His posts are very informative!
Kind of interesting how CTIX has traded very little in the 3.20's in the last 3 weeks. Almost skips them whether up or down action. Hardly any volume last 80 minutes.
Low volume for this down day. Nothing abnormal in the trading activity.
Nope didn't sell any and have powder to add. Green to All
CTIX
News trumps TA....good luck!
123tom... your TA skills are most impressive and your posts are the post of the day any day!
Monday 11/10/2014 - "IF price rallies strong above 3.20 and on to retest the 3.50 top, and then pulls back and Holds strong support above 3.00-3.15 then the pattern starts to regain bullish momentum.
probably needs the whole week to play out this kind of price action.
Wednesday 11/12/214 -"Pullback could be a nice and positive one if it holds strong above 3 dollars now.... 3.15 would be perfect."
Thursday 11/13/2014 - "my guess is that price will retreat to test the support 3.30-3.20,for starters, ...
it might hold there or might fall to the next step lower 3.17/3.10/3.05 and hold there....and then try to retest 3.45 top zone again
IF it falls to the 50 % Fib around 3.10, and then somehow fails or falters at 3.25 ,resistance, it has a possibility to fall again back down to test the 3.00 and then 2.85 bottom zone.
Its all about bouncing between Support and Resistance levels.
IF Great news comes out at any time, the rocket takes off ,of course.
IF no news, then technical trading bounces between S/R points
IF no news comes out , technical pressure favors a pullback,just like the last one that fell to 2.85 area.
this can happen 2 or 3 more times. in a sideways Range, .....
if there's no news."
Like BioHedge said, I've never met a wealthy short-term trader.
With big PRs possible every Monday through year-end, I'd anticipate a regular pattern of very bullish Friday trading for weeks to come. Smart idea to start nibbling here, imho. eom
As I have repeated many times, I use mental stops to keep my emotions in check. I had expected CTIX to make a run for $3.50 and then test. But, didn't happen. Instead, I got stopped out at from $3.35 to $3.28 this morning. About a 12% profit.
Now waiting to reenter. Would like to see a bit of consolidation. Starting to see the pattern of "sell on the news" developing.
I am very mindful that CTIX has come a long ways in a short time, these past few months.
I have a feeling we will get an OTC-BB (Pink Sheets) update early next week with possible update on uplisting plans.
Let's hope so!
You've got it pegged right here...continued gradual uptrend punctuated by 10-30% pullbacks. Bottom BB 2.80 would be 20% from the 3.50 high.
.....great album, great midnight movie back in the late seventies
Dana Farber has the latest in tumor mapping techniques.
Doc,
Did you happen to see my earlier post to you? #78142
Curious about your thoughts.
Not sure, but what did you do to the share price today?
Stock goes up, stock goes down...The Song Remains the Same. CTIX looooooong.
Lol. Well done. eom
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 11/10/2014 5:31:51 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/10/2014 4:16:35 PM
Hot Stocks to Follow for Investment Opportunity & Special Profile "InvestorsHub NewsWire" - 11/6/2014 6:00:00 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 10/30/2014 4:31:15 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/24/2014 6:04:28 AM
ALTITRADE PARTNERS™ SAYS A KEY-REVERSAL DAY COULD HAPPEN THIS WEEK "InvestorsHub NewsWire" - 10/14/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/24/2014 3:48:22 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 9/15/2014 1:50:04 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 9/4/2014 4:14:23 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/2/2014 6:29:26 AM
Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant "Marketwired" - 6/23/2014 7:00:00 AM
Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin Entering Eighth Cohort "Marketwired" - 6/16/2014 7:00:00 AM
Cellceutix Completes Patient Enrollment in Clinical Trial of Prurisol "Marketwired" - 6/2/2014 7:00:00 AM
Cellceutix Signs Material Transfer Agreements for Defensin Mimetic Compounds With Leading Universities "Marketwired" - 5/27/2014 7:00:00 AM
Cellceutix Plans for Entry in Diabetic Foot Wound and Ulcer Market "Marketwired" - 5/19/2014 7:00:00 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 5/16/2014 11:57:54 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/12/2014 10:12:29 AM
Cellceutix Confident in Its Formidable Antibiotic Arsenal "Marketwired" - 5/12/2014 7:00:00 AM
Cohort Completed in Cellceutix Clinical Trial of Prurisol for Psoriasis "Marketwired" - 5/5/2014 9:53:20 AM
Study Shows Cellceutix Antibiotic Active Against Drug-Resistant Superbug Klebsiella Pneumoniae "Marketwired" - 4/14/2014 6:30:00 AM
Cellceutix Comments on Positive FDA Advisory Vote for Dalbavancin and Tedizolid "Marketwired" - 4/1/2014 8:00:00 AM
Cellceutix Reports 20 Percent Enrollment Completed in Phase 2b Trial of Brilacidin as Short-Course Therapy for ABSSSI "Marketwired" - 3/31/2014 9:25:00 AM
Cellceutix Initiates Clinical Trial of Prurisol as New Treatment for Psoriasis "Marketwired" - 3/25/2014 6:00:00 AM
Cellceutix to Initiate Psoriasis Clinical Trial "Marketwired" - 3/21/2014 6:00:00 AM
Seventh Cohort Underway in Cellceutix Clinical Trial of Kevetrin for Solid Tumors "Marketwired" - 3/19/2014 8:40:37 AM
No problem.
"I did not connect Operating history with Revenue."
Keep in mind that I CONCLUDED the meaning from anecdotal stuff....Every instance where I found the phrase "no operating history" the company also had no revenue. I never found a source that said "a company's operating history is measured from the time it first has revenue". If you see a reliable source that either confirms or refutes my understanding please be sure to post it.
yikes!
Look up 'Uri Geller'. Or actually track the results of 123tom's technical analysis predictions, it'll enhance your definition of informative
gosh, people that sell now...are so S !
"Most mistakes made by investors is knowing when to sell" Now is the wrong time! Wait for Leo and Menon to sell some of their shares. Familyman said it best!
That is what I have said! His posts are very informative!
Kind of interesting how CTIX has traded very little in the 3.20's in the last 3 weeks. Almost skips them whether up or down action. Hardly any volume last 80 minutes.
Low volume for this down day. Nothing abnormal in the trading activity.
Nope didn't sell any and have powder to add. Green to All
CTIX
News trumps TA....good luck!
123tom... your TA skills are most impressive and your posts are the post of the day any day!
Monday 11/10/2014 - "IF price rallies strong above 3.20 and on to retest the 3.50 top, and then pulls back and Holds strong support above 3.00-3.15 then the pattern starts to regain bullish momentum.
probably needs the whole week to play out this kind of price action.
Wednesday 11/12/214 -"Pullback could be a nice and positive one if it holds strong above 3 dollars now.... 3.15 would be perfect."
Thursday 11/13/2014 - "my guess is that price will retreat to test the support 3.30-3.20,for starters, ...
it might hold there or might fall to the next step lower 3.17/3.10/3.05 and hold there....and then try to retest 3.45 top zone again
IF it falls to the 50 % Fib around 3.10, and then somehow fails or falters at 3.25 ,resistance, it has a possibility to fall again back down to test the 3.00 and then 2.85 bottom zone.
Its all about bouncing between Support and Resistance levels.
IF Great news comes out at any time, the rocket takes off ,of course.
IF no news, then technical trading bounces between S/R points
IF no news comes out , technical pressure favors a pullback,just like the last one that fell to 2.85 area.
this can happen 2 or 3 more times. in a sideways Range, .....
if there's no news."
Like BioHedge said, I've never met a wealthy short-term trader.
With big PRs possible every Monday through year-end, I'd anticipate a regular pattern of very bullish Friday trading for weeks to come. Smart idea to start nibbling here, imho. eom
As I have repeated many times, I use mental stops to keep my emotions in check. I had expected CTIX to make a run for $3.50 and then test. But, didn't happen. Instead, I got stopped out at from $3.35 to $3.28 this morning. About a 12% profit.
Now waiting to reenter. Would like to see a bit of consolidation. Starting to see the pattern of "sell on the news" developing.
I am very mindful that CTIX has come a long ways in a short time, these past few months.
I have a feeling we will get an OTC-BB (Pink Sheets) update early next week with possible update on uplisting plans.
Let's hope so!
You've got it pegged right here...continued gradual uptrend punctuated by 10-30% pullbacks. Bottom BB 2.80 would be 20% from the 3.50 high.
.....great album, great midnight movie back in the late seventies
Dana Farber has the latest in tumor mapping techniques.
Doc,
Did you happen to see my earlier post to you? #78142
Curious about your thoughts.
Not sure, but what did you do to the share price today?
Stock goes up, stock goes down...The Song Remains the Same. CTIX looooooong.
Lol. Well done. eom
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 11/10/2014 5:31:51 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/10/2014 4:16:35 PM
Hot Stocks to Follow for Investment Opportunity & Special Profile "InvestorsHub NewsWire" - 11/6/2014 6:00:00 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 10/30/2014 4:31:15 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/24/2014 6:04:28 AM
ALTITRADE PARTNERS™ SAYS A KEY-REVERSAL DAY COULD HAPPEN THIS WEEK "InvestorsHub NewsWire" - 10/14/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/24/2014 3:48:22 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 9/15/2014 1:50:04 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 9/4/2014 4:14:23 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/2/2014 6:29:26 AM
Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant "Marketwired" - 6/23/2014 7:00:00 AM
Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin Entering Eighth Cohort "Marketwired" - 6/16/2014 7:00:00 AM
Cellceutix Completes Patient Enrollment in Clinical Trial of Prurisol "Marketwired" - 6/2/2014 7:00:00 AM
Cellceutix Signs Material Transfer Agreements for Defensin Mimetic Compounds With Leading Universities "Marketwired" - 5/27/2014 7:00:00 AM
Cellceutix Plans for Entry in Diabetic Foot Wound and Ulcer Market "Marketwired" - 5/19/2014 7:00:00 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 5/16/2014 11:57:54 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/12/2014 10:12:29 AM
Cellceutix Confident in Its Formidable Antibiotic Arsenal "Marketwired" - 5/12/2014 7:00:00 AM
Cohort Completed in Cellceutix Clinical Trial of Prurisol for Psoriasis "Marketwired" - 5/5/2014 9:53:20 AM
Study Shows Cellceutix Antibiotic Active Against Drug-Resistant Superbug Klebsiella Pneumoniae "Marketwired" - 4/14/2014 6:30:00 AM
Cellceutix Comments on Positive FDA Advisory Vote for Dalbavancin and Tedizolid "Marketwired" - 4/1/2014 8:00:00 AM
Cellceutix Reports 20 Percent Enrollment Completed in Phase 2b Trial of Brilacidin as Short-Course Therapy for ABSSSI "Marketwired" - 3/31/2014 9:25:00 AM
Cellceutix Initiates Clinical Trial of Prurisol as New Treatment for Psoriasis "Marketwired" - 3/25/2014 6:00:00 AM
Cellceutix to Initiate Psoriasis Clinical Trial "Marketwired" - 3/21/2014 6:00:00 AM
Seventh Cohort Underway in Cellceutix Clinical Trial of Kevetrin for Solid Tumors "Marketwired" - 3/19/2014 8:40:37 AM
